Automated Endoscope Reprocessors Sales

Automated Endoscope Reprocessors Sales Market Outlook

The global Automated Endoscope Reprocessors (AER) market is projected to reach USD 1.2 billion by 2035, growing at a CAGR of approximately 8% during the forecast period from 2025 to 2035. This growth is primarily driven by the increasing number of minimally invasive surgeries, rising awareness about infection control in healthcare settings, and advancements in medical technology that enhance the efficiency of endoscope processing. Moreover, the growing prevalence of gastrointestinal diseases globally has led to an increase in the use of endoscopic procedures, subsequently propelling the demand for automated endoscope reprocessors in hospitals and surgical centers. The necessity for stringent sterilization and reprocessing protocols in minimally invasive surgical procedures further emphasizes the significance of AER systems, as they ensure optimal patient safety and compliance with health regulations.

Growth Factor of the Market

The Automated Endoscope Reprocessors market is witnessing robust growth, primarily due to the escalating number of surgeries that require the use of endoscopes, along with the rising standards of sterilization procedures in healthcare facilities. The adoption of advanced technologies in the healthcare sector, including automation and smart technologies, is also significantly boosting the market. Additionally, the increasing focus on patient safety and the reduction of healthcare-associated infections (HAIs) are compelling healthcare providers to invest in efficient reprocessing solutions. The growing geriatric population, which is more susceptible to gastrointestinal disorders, is further enhancing the demand for endoscopic procedures, thus driving the AER market. Moreover, the introduction of new and improved AER models that offer superior efficiency and lower operational costs are making them a preferred choice among healthcare practitioners.

Key Highlights of the Market

• Growing demand for minimally invasive surgical procedures driving AER adoption.
• Technological advancements enhancing the efficiency and reliability of reprocessing systems.
• Increasing awareness about infection prevention measures in healthcare facilities.
• Rise in gastrointestinal diseases contributing to a higher volume of endoscopic interventions.
• Regulatory push for stringent sterilization standards in hospitals and clinics.

By Product Type

Single Basin Automated Endoscope Reprocessors:

Single Basin Automated Endoscope Reprocessors are designed for effective washing and disinfecting of endoscopes using a single basin. These models are typically compact and user-friendly, making them suitable for smaller healthcare facilities where space is a constraint. They utilize a combination of detergents and rinsing solutions to ensure thorough cleaning, which is essential to prevent cross-contamination. With their growing adoption in outpatient clinics and smaller hospitals, single basin reprocessors are gaining traction due to their lower operational costs and ease of use. As healthcare facilities increasingly recognize the importance of infection control, the demand for these reprocessors is projected to rise steadily.

Double Basin Automated Endoscope Reprocessors:

Double Basin Automated Endoscope Reprocessors provide enhanced cleaning capabilities by featuring two separate basins for pre-cleaning and disinfection processes. This design allows for a more effective cleaning cycle, thereby reducing the risk of infection associated with poorly processed endoscopes. The ability to process multiple endoscopes efficiently makes double basin models particularly suitable for hospitals and surgical centers with high patient turnover. Their advanced features, which include automated cycles and user-friendly interfaces, support compliance with strict infection control protocols. As hospitals seek to improve their operational efficiency while maintaining high standards of patient safety, the adoption of double basin AER systems is expected to grow in the coming years.

Triple Basin Automated Endoscope Reprocessors:

Triple Basin Automated Endoscope Reprocessors are designed for maximum efficiency and thorough cleaning, incorporating three basins for cleaning, rinsing, and disinfecting. This configuration allows for a comprehensive reprocessing cycle that significantly enhances the safety and readiness of endoscopes for subsequent procedures. Facilities that handle a large volume of endoscopic procedures, such as teaching hospitals, increasingly favor these systems for their ability to process multiple instruments simultaneously. The advanced automation and integrated monitoring systems help in maintaining the integrity of sterilization processes, thereby ensuring optimal compliance with health and safety regulations. As the demand for higher throughput and efficiency in endoscope reprocessing rises, the market for triple basin reprocessors is anticipated to expand considerably.

Quadruple Basin Automated Endoscope Reprocessors:

Quadruple Basin Automated Endoscope Reprocessors offer the ultimate solution for healthcare facilities that require high-capacity disinfection systems. These advanced units include four basins, enabling simultaneous cleaning, rinsing, and multiple disinfection stages, which ensures the highest level of sterility. Designed for large hospitals and surgical centers where the volume of endoscopic procedures is substantial, these reprocessors provide unparalleled efficiency and thoroughness in sterilization. The integrated technology in quadruple basin systems often includes real-time monitoring and documentation capabilities, which help healthcare providers comply with rigorous infection control standards. The increasing need for high-efficiency reprocessing systems is likely to drive the demand for quadruple basin reprocessors significantly in the near future.

Others:

In addition to the primary product types mentioned, the market also includes various automated endoscope reprocessors that do not fit into the defined categories. These may include customized solutions tailored to meet specific needs of particular healthcare facilities or specialized endoscopic procedures. Innovations in materials and technologies are leading to the development of new AER systems that focus on sustainability, ease of maintenance, and enhanced performance. As healthcare providers continue to seek innovative solutions that cater to unique operational requirements, the segment for other types of automated endoscope reprocessors is expected to experience notable growth, complementing the broader market trend.

By Application

Hospitals:

Hospitals represent the largest application segment for Automated Endoscope Reprocessors as they are the primary centers for performing a wide range of endoscopic procedures. The need for stringent sterilization and reprocessing protocols is paramount in hospitals, given the high volume of procedures conducted daily. AER systems in hospitals ensure that endoscopes are cleaned and disinfected effectively, thereby minimizing the risk of healthcare-associated infections. With increasing admissions for gastrointestinal diseases and a growing emphasis on patient safety, hospitals are increasingly investing in advanced AER technologies. This trend is anticipated to continue, further propelling the demand for automated reprocessing solutions in hospital settings.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) are rapidly adopting Automated Endoscope Reprocessors to enhance their operational efficiency and patient safety. These centers focus on providing outpatient care and require reliable reprocessing systems to ensure that endoscopes are ready for immediate use after procedures. The integration of AER systems streamlines the workflow in ASCs, allowing for quicker turnaround times and reduced labor costs associated with manual cleaning methods. As the number of minimally invasive surgeries performed in ASCs continues to rise, the demand for AER solutions tailored for these settings is expected to grow significantly in the coming years.

Clinics:

Clinics are increasingly implementing Automated Endoscope Reprocessors to comply with stringent infection control standards while maintaining operational efficiency. These facilities often perform a variety of endoscopic procedures, and the reliability of reprocessing solutions is critical for ensuring patient safety. AER systems designed for clinics typically focus on compact design and ease of use, making them ideal for smaller settings. As regulations around infection prevention become more stringent, clinics are likely to invest more in automated solutions to enhance their reprocessing capabilities, thereby supporting the overall growth of the AER market.

Diagnostic Centers:

Diagnostic Centers play a crucial role in the application of Automated Endoscope Reprocessors, particularly as they increasingly conduct endoscopy-related diagnostic procedures. The demand for high-quality reprocessing solutions is amplified in diagnostic centers to prevent cross-contamination and ensure accurate results. Automated systems provide these centers with the ability to efficiently process endoscopes while adhering to regulatory standards. The rising prevalence of various gastrointestinal diseases necessitates the use of endoscopic diagnosis, further propelling the need for effective AER solutions in diagnostic facilities.

Others:

The 'Others' segment encompasses diverse applications that utilize automated endoscope reprocessors beyond the typical hospital or clinic settings. This includes research laboratories, specialized medical institutes, and mobile health units where endoscopic procedures are performed. These unique environments often have specific reprocessing needs that are addressed by tailored AER solutions. As the healthcare landscape evolves with new applications for endoscopic procedures emerging, the market for automated endoscope reprocessors in these non-traditional settings is expected to expand, adding to the overall growth of the industry.

By Distribution Channel

Direct Sales:

Direct sales represent a significant distribution channel in the Automated Endoscope Reprocessors market, wherein manufacturers engage directly with hospitals and healthcare facilities to sell their products. This approach allows for personalized service, tailored solutions, and comprehensive post-sale support, which is crucial in the medical field. With the increasing complexity and technological advancements in AER systems, direct sales enable manufacturers to provide better technical support and training for healthcare staff, ensuring optimal usage of the equipment. As the demand for specialized reprocessing solutions grows, direct sales channels are likely to expand further, enhancing the customer experience and building lasting relationships between sellers and buyers.

Indirect Sales:

Indirect sales are essential in the Automated Endoscope Reprocessors market, involving a network of distributors and resellers who facilitate the delivery of these medical devices to various healthcare facilities. This distribution method is particularly beneficial for reaching smaller clinics, ambulatory centers, and hospitals that may not have direct access to manufacturers. Indirect sales channels often include partnerships with medical supply companies, which can provide added value through bundled services and logistics support. As the market continues to expand, the indirect sales channel is expected to play a crucial role in ensuring that AER solutions are widely available across diverse healthcare settings.

By Technology

Water-based Automated Endoscope Reprocessors:

Water-based Automated Endoscope Reprocessors utilize a combination of water, detergents, and disinfectants to clean and process endoscopes effectively. This technology is widely favored for its ability to remove organic matter and biofilms that may otherwise remain on endoscopes after procedures. Water-based systems are designed to operate with various water quality levels, making them adaptable for different healthcare settings. Additionally, these systems often feature automated cycles to enhance consistency and reliability in the cleaning process. As the emphasis on infection control increases, the usage of water-based AER systems is projected to continue on a growth trajectory.

Gas-based Automated Endoscope Reprocessors:

Gas-based Automated Endoscope Reprocessors employ gaseous agents to disinfect endoscopes, representing a cutting-edge approach to reprocessing. These systems typically utilize ethylene oxide or hydrogen peroxide gas to achieve rapid and effective sterilization. The advantages of gas-based reprocessors include their ability to penetrate complex instruments and eliminate microbial life without leaving harmful residues. Their effectiveness in achieving high levels of sterility makes them suitable for use in facilities with stringent infection control protocols. As healthcare facilities strive to improve their sterilization practices, gas-based systems are gaining popularity, contributing to market growth.

Detergent-based Automated Endoscope Reprocessors:

Detergent-based Automated Endoscope Reprocessors focus on the use of specialized detergents designed to break down organic matter and clean endoscopes efficiently. These systems are particularly effective in eliminating biological contaminants that could compromise patient safety. By employing advanced detergent formulations, these AER systems ensure that endoscopes are thoroughly cleaned and decontaminated, preparing them for safe reuse in medical procedures. The increasing awareness of the importance of thorough cleaning in infection prevention is driving the adoption of detergent-based reprocessors. As a result, this segment is anticipated to grow significantly in response to the rising demand for high-quality cleaning solutions in healthcare settings.

Others:

The 'Others' category includes various innovative technologies that may not fall into the conventional classifications of AER systems. This includes hybrid systems that integrate multiple cleaning methods, including enzymatic solutions or ultraviolet (UV) light disinfection technologies. These advancements aim to improve the efficacy and efficiency of endoscope reprocessing, catering to the unique needs of specific healthcare environments. As innovations continue to emerge, the 'Others' segment is expected to grow and diversify, providing healthcare facilities with options that enhance their reprocessing capabilities while ensuring patient safety.

By Region

The North American region dominates the Automated Endoscope Reprocessors market, accounting for approximately 35% of the total market share in 2023. The growth in this region can be attributed to the presence of advanced healthcare infrastructure, a high prevalence of gastrointestinal diseases, and stringent regulations regarding infection control. Moreover, the increasing adoption of minimally invasive surgical procedures is expected to further drive the demand for AER systems. The market is projected to grow at a CAGR of around 8.5% from 2025 to 2035 as healthcare facilities continue to prioritize patient safety and invest in modern reprocessing technologies.

In Europe, the Automated Endoscope Reprocessors market is also experiencing significant growth, primarily driven by an increase in healthcare expenditures and a focus on improving patient outcomes through effective infection control measures. The market in this region is expected to capture around 30% of the global share by 2035, as more hospitals and surgical centers adopt automated reprocessing solutions. Additionally, the European market is characterized by a growing emphasis on regulatory compliance and safety standards, which will facilitate the adoption of advanced AER systems. Countries such as Germany, France, and the UK are leading the charge, reflecting a strong commitment to investing in healthcare technology.

Opportunities

As the global healthcare landscape continues to evolve, numerous opportunities exist for the Automated Endoscope Reprocessors market. One of the most significant opportunities lies in the increasing demand for minimally invasive surgical procedures, which has been steadily rising due to their benefits, such as reduced recovery times and lower complication rates. This trend necessitates a corresponding increase in the availability of effective and reliable reprocessing systems to ensure that endoscopes are thoroughly cleaned and disinfected for repeated use. Additionally, the growing emphasis on patient safety and stringent infection control protocols presents a favorable environment for the adoption of automated endoscope reprocessors. As healthcare facilities strive to meet regulatory standards and improve patient outcomes, they are likely to invest more in advanced AER technologies, thus creating ample growth prospects for manufacturers in this sector.

Furthermore, the ongoing technological advancements in automated endoscope reprocessors present exciting opportunities for innovation and growth. The integration of smart technologies, such as IoT-enabled devices and real-time monitoring, is revolutionizing the way endoscope reprocessing is managed. These innovations enhance operational efficiency, reduce human error, and provide healthcare facilities with valuable data related to sterilization processes. As manufacturers continue to develop next-generation AER systems that leverage these technologies, they can capture new market segments and expand their reach within the healthcare sector. The growing focus on sustainable practices in healthcare is also an opportunity, with manufacturers exploring eco-friendly materials and processes in their reprocessing solutions to align with environmental goals advocated by various institutions.

Threats

The Automated Endoscope Reprocessors market faces several threats that could hinder its growth trajectory. One of the primary challenges is the high initial investment required for the implementation of automated reprocessing systems. Many smaller healthcare facilities may struggle to afford the upfront costs associated with purchasing and installing advanced AER systems. This financial barrier can limit the market penetration of innovative reprocessing technologies, particularly in underfunded clinics and hospitals. Additionally, economic fluctuations and budget constraints in healthcare systems can lead to reduced spending on medical equipment, further affecting the growth of the AER market. Furthermore, there is competition from alternative cleaning methods, such as manual reprocessing, which may still be preferred in some facilities due to cost considerations or familiarity with traditional practices.

Another threat to the market includes the potential for regulatory changes that could impact the manufacturing and distribution of automated endoscope reprocessors. Stringent regulations governing medical devices can result in increased compliance costs for manufacturers, potentially stifling innovation and slowing the introduction of new products. Additionally, the rapid pace of technological advancement means that companies must continuously adapt to stay competitive; failure to do so could lead to obsolescence. Finally, there is an inherent risk associated with product recalls or safety issues, which can damage brand reputation and lead to a loss of consumer trust in automated reprocessing solutions.

Competitor Outlook

• Steris Corporation
• Olympus Corporation
• Getinge Group
• 3M Company
• Advanced Sterilization Products (ASP)
• Medivators Inc.
• Fujifilm Corporation
• Robert Bosch GmbH
• Hygiena LLC
• Cardinal Health
• Pentax Medical Company
• Belimed AG
• STERIS Isomedix Services, Inc.
• EndoChoice, Inc.
• Shinva Medical Instrument Co., Ltd.

The competitive landscape of the Automated Endoscope Reprocessors market is characterized by the presence of several key players who are actively innovating and expanding their product offerings to capture market share. Companies like Steris Corporation and Olympus Corporation lead the market, leveraging their extensive experience and technological prowess to develop advanced reprocessing solutions that meet the stringent demands of healthcare facilities. These market leaders invest heavily in research and development to enhance their product features, improve efficiency, and ensure compliance with evolving regulatory standards. Additionally, strategic partnerships and collaborations with healthcare providers enable these companies to gain valuable insights into customer needs, allowing them to tailor their offerings accordingly.

Emerging players, such as Advanced Sterilization Products (ASP) and Medivators Inc., are also making significant strides in the market by introducing innovative automated endoscope reprocessors that focus on user-friendliness and operational efficiency. These companies emphasize the importance of customer support and training, ensuring that healthcare facilities can maximize the benefits of their reprocessing systems. The competitive dynamics of the market are further fueled by ongoing technological advancements, which necessitate constant adaptation and improvement among players. Companies that can successfully differentiate themselves through unique value propositions, such as eco-friendly solutions or advanced monitoring features, are likely to capture a larger share of the market.

As the market continues to evolve, other notable companies such as Getinge Group and 3M Company are expanding their presence by focusing on geographical diversification and tapping into emerging markets. These companies recognize the potential for growth in regions where healthcare infrastructures are rapidly developing or where there is an increasing emphasis on infection control. By aligning their strategies with regional healthcare demands and regulatory frameworks, these players are well-positioned to benefit from the growing trend of automated reprocessing solutions. Furthermore, established players like Fujifilm Corporation and Cardinal Health are continually enhancing their portfolios through acquisitions and strategic collaborations, further strengthening their competitive positions in the Automated Endoscope Reprocessors market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 3M Company
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Belimed AG
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Hygiena LLC
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Getinge Group
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Cardinal Health
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Medivators Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 EndoChoice, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Robert Bosch GmbH
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Steris Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Olympus Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Fujifilm Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Pentax Medical Company
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 STERIS Isomedix Services, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Shinva Medical Instrument Co., Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Advanced Sterilization Products (ASP)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Automated Endoscope Reprocessors Sales Market, By Technology
    • 6.1.1 Water-based Automated Endoscope Reprocessors
    • 6.1.2 Gas-based Automated Endoscope Reprocessors
    • 6.1.3 Detergent-based Automated Endoscope Reprocessors
    • 6.1.4 Others
  • 6.2 Automated Endoscope Reprocessors Sales Market, By Application
    • 6.2.1 Hospitals
    • 6.2.2 Ambulatory Surgical Centers
    • 6.2.3 Clinics
    • 6.2.4 Diagnostic Centers
    • 6.2.5 Others
  • 6.3 Automated Endoscope Reprocessors Sales Market, By Product Type
    • 6.3.1 Single Basin Automated Endoscope Reprocessors
    • 6.3.2 Double Basin Automated Endoscope Reprocessors
    • 6.3.3 Triple Basin Automated Endoscope Reprocessors
    • 6.3.4 Quadruple Basin Automated Endoscope Reprocessors
    • 6.3.5 Others
  • 6.4 Automated Endoscope Reprocessors Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Indirect Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Automated Endoscope Reprocessors Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Automated Endoscope Reprocessors Sales market is categorized based on

By Product Type

• Single Basin Automated Endoscope Reprocessors
• Double Basin Automated Endoscope Reprocessors
• Triple Basin Automated Endoscope Reprocessors
• Quadruple Basin Automated Endoscope Reprocessors
• Others

By Application

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Diagnostic Centers
• Others

By Distribution Channel

• Direct Sales
• Indirect Sales

By Technology

• Water-based Automated Endoscope Reprocessors
• Gas-based Automated Endoscope Reprocessors
• Detergent-based Automated Endoscope Reprocessors
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Steris Corporation
• Olympus Corporation
• Getinge Group
• 3M Company
• Advanced Sterilization Products (ASP)
• Medivators Inc.
• Fujifilm Corporation
• Robert Bosch GmbH
• Hygiena LLC
• Cardinal Health
• Pentax Medical Company
• Belimed AG
• STERIS Isomedix Services, Inc.
• EndoChoice, Inc.
• Shinva Medical Instrument Co., Ltd.